Evidence map›Paper›PMID 10381671›Full record

ArticleThe British journal of ophthalmology1999

Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.

K Shinoda, S Ishida, S Kawashima, T Wakabayashi, T Matsuzaki, M Takayama, K Shinmura, M Yamada

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The British journal of ophthalmology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Endothelial Dysfunction in Diabetic Retinopathy.Frontiers in endocrinology · 2020
    Review
  9. Article
  10. Time-dependent expression of PEDF and VEGF in blood serum and retina of rats with oxygen-induced retinopathy.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2015
    Article
  11. Review
  12. Modulation of CD44 Activity by A6-Peptide.Frontiers in immunology · 2015
    Review
  13. Article
  14. Article
  15. The pathologic continuum of diabetic vascular disease.Journal of the American College of Cardiology · 2009
    Review
  16. Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2003
    Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

K ShinodaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
S Ishida
S Kawashima
T Wakabayashi
T Matsuzaki
M Takayama
K Shinmura
M Yamada
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo determine the relation between the stages of diabetic retinopathy (DR) and the levels of hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) in aqueous fluid and serum.

methodsLevels of HGF and VEGF in serum and aqueous humour obtained during ocular surgery were measured by enzyme linked immunosorbent assay in 58 diabetic patients with 32 non-diabetic patients (NDM) as controls. The patients with diabetes were classified into three groups according to the stage of DR: no DR (NDR; 15 cases), non-proliferative DR (NPDR; six cases), and proliferative DR (PDR; 37 cases).

resultsNo significant differences were found between any of the groups in serum concentrations of HGF or VEGF. The aqueous HGF levels increased with the stage of DR: NDM, median 397 pg/ml, range 133-930 pg/ml; NDR, 371 pg/ml, 142-1536 pg/ml; NPDR, 455 pg/ml, 162-1007 pg/ml; and PDR, 638 pg/ml, 187-2222 pg/ml. The aqueous VEGF levels in PDR (median 212 pg/ml, range 14-1216 pg/ml) were significantly higher than in NDM (105 pg/ml, 9-203 pg/ml), but aqueous HGF concentrations were unrelated to those of VEGF.

conclusionThe results of the present study suggest that both HGF and VEGF present in the ocular tissues may play important roles in the progression of DR.

Indexed as

AdultAgedAged, 80 and overAqueous HumorBiomarkersDiabetes MellitusDiabetic RetinopathyDisease ProgressionEndothelial Growth FactorsEnzyme-Linked Immunosorbent AssayHepatocyte Growth FactorHumansLymphokinesMiddle AgedVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsBiomarkersEndothelial Growth FactorsHepatocyte Growth FactorLymphokinesVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID10381671
PMCPMC1723111
OpenAlexW2128869740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.